Outcome of Autologous Stem Cell Transplant in Relapsed/Refractory Hodgkin Lymphoma - A Single Center Study
{{output}}
Introduction: In relapsed/refractory (R/R) classic Hodgkin lymphoma (cHL), the preferred treatment is autologous stem cell transplantation (ASCT) after receiving high-dose chemotherapy (HDC). Here, we describe and discuss the sin... ...
